DERM
Journey Medical Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.31
−0.68%Forward multiples
Based on analyst estimates
- P/E forward
- 37.01x
- P/E 2026E
- —
- P/E 2027E
- 10.87x
- P/E 2028E
- 4.45x
- P/S forward
- 2.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.42x
- Price / sales
- 3.03x
- Price / cash flow
- -27.54x
Enterprise value
- Enterprise value
- $206.2M
- EV / sales
- 3.02x
- EV / EBITDA
- 111.53x
- EV / EBIT
- -68.56x
- Market cap
- $206.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026